GSK has asked Angus Council for advice as it prepares to submit a planning application for an API plant it intends to build at its site in Montrose, Scotland.
Titan Pharmaceuticals has put plans for a trial of its candidate Parkinson’s disease implant ropinirole after the US FDA asked for additional information.
Merck & Co. has put an Irish small molecule plant up for sale after ceasing production late last year.
Fujifilm has separated its biopharmaceutical contracting business in an effort to triple its revenues to ¥100bn ($890m) within seven years.
Data is a core competence for Big Pharma that should not be outsourced, according to an industry statistics expert.
GSK says the closing of its Costa Rica manufacturing facility is necessary to ensure the long-term viability of its consumer healthcare business.
Dr Reddy’s Laboratories has been issued with a Form483 after an inspection at its active pharmaceutical ingredient (API) plant in Miryalaguda in Telangana, India.
Ohr Pharmaceutical Inc. has halted activities at the laboratory in San Diego, California where research on its sustained release delivery technology was carried out.
Several organizations have penned an open letter to NIH urging it adhere to 21st Century Cures deadlines that if missed, will affect improvements to ClinicalTrials.gov – and ultimately, study start up.